Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 277-284

  Fukumoto, Akihisa ^a   Ikeda, Naoya ^a   Sho, Masayuki ^a   Tomoda, Kiichiro ^b   Kanehiro, Hiromichi ^a   Hisanaga, Michiyoshi ^a   Tsurui, Yoshikazu ^a   Tsutsumi, Masahiro ^a   Kato, Jun Ya ^b   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

CSN5; Jab1; Pancreatic cancer; Prognosis

Indexed keywords

CELL CYCLE PROTEIN; COPS5 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA BINDING PROTEIN; PEPTIDE HYDROLASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROTEIN TRANSPORT; SURVIVAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PEPTIDE HYDROLASES; PROPORTIONAL HAZARDS MODELS; PROTEIN TRANSPORT; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 3242806804     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.277     Document Type: Article

References (30)

1. Nitecki SS, Sarr MG, Colby TV and van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221: 59-66, 1995.
2. Conlon KC, Klimstra DS and Brennan MF: Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223: 273-279, 1996. (Pubitemid 26086718)
3. Beger HG, Gansauge F and Leder G: Pancreatic cancer: who benefits from curative resection? Can J Gastroenterol 16: 117-120, 2002. (Pubitemid 34406661)
4. Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, Nakaizumi A, Uehara H, Tanaka S and Takenaka A: Radical resection for pancreatic cancer. Acta Gastroenterol Belg 65: 166-170, 2002.
5. Bardeesy N and DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909, 2002. (Pubitemid 37328891)
6. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H and Miyake M: Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79: 1553-1563, 1999. (Pubitemid 29116820)
7. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H and Miyake M: Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79: 509-516, 1998. (Pubitemid 28445274)
8. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI and Slingerland JM: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3: 227-230, 1997. (Pubitemid 27064710)
9. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997. (Pubitemid 27064709)
10. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3: 231-234, 1997. (Pubitemid 27064711)
11. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH and Slingerland JM: Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 58: 542-548, 1998. (Pubitemid 28087420)
12. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997. (Pubitemid 27355479)
13. Lu CD, Morita S, Ishibashi T, Hara H, Isozaki H and Tanigawa N: Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma. Cancer 85: 1250-1260, 1999. (Pubitemid 29125077)
14. Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ: The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396: 177-180, 1998. (Pubitemid 28523620)
15. Hengst L and Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861-1864, 1996.
16. Slingerland I and Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183: 10-17, 2000.
17. Claret FX, Hibi M, Dhut S, Toda T and Karin M: A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383: 453-457, 1996. (Pubitemid 26330837)
18. Tomoda K, Kubota Y and Kato J: Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160-165, 1999.
19. Sobin LH WC: TNM classification of malignant tumors. 5th edition. John Wiley & Sons, Inc., New York, 1997.
20. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995.
21. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y and Tokuda M: Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 7: 4130-4135, 2001. (Pubitemid 34044637)
22. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX and Grossman AB: Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab 87: 2635-2643, 2002. (Pubitemid 34655325)
23. Shen L, Tsuchida R, Miyauchi J, Saeki M, Honna T, Tsunematsu Y, Kato J and Mizutani S: Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma. Int J Oncol 17: 749-754, 2000.
24. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E and Slingerland JM: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160, 2002. (Pubitemid 35175971)
25. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C and Dubiel W: COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20: 1630-1639, 2001. (Pubitemid 32299400)
26. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M and Dubiel W: A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 12: 469-478, 1998. (Pubitemid 28146526)
27. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A and Santoro M: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144, 2002. (Pubitemid 35175969)
28. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J and Arteaga CL: PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152, 2002. (Pubitemid 35175970)
29. Park KH, Seol JY, Kim TY, Yoo CG, Kim YW, Han SK, Shim YS and Lee CT: An adenovirus expressing mutant p27 showed more potent antitumor effects than adenovirus-p27 wild-type. Cancer Res 61: 6163-6169, 2001. (Pubitemid 32762554)
30. Naruse I, Hoshino H, Dobashi K, Minato K, Saito R and Mori M: Over-expression of p27kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell lines. Int J Cancer 88: 377-383, 2000.